Clinical Trial

Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

Study acronym: ICONA
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to identify the most promising treatment sequence in total neoadjuvant therapy for locally advanced rectal cancer with a high risk of recurrence.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-09-19.
Status change: Recruiting → Active, Not Recruiting 2026-07-08
Trial Details
NCT Number NCT05054959
Lead Sponsor Institute of Oncology Ljubljana
Conditions Locally Advanced Rectal Cancer
Enrollment 62 participants
Start Date 2021-06-24
Primary Completion 2023-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-09